Afabicin (Debio1450) is a prodrug of Debio1452, exhibiting activity against staphylococci but showing no significant effect against other Gram-positive or Gram-negative bacteria; Debio1452 acts as a FabI inhibitor, inhibiting fatty acid synthesis in staphylococci.